References
1. Steven DW, Alaghband P, Lim KS. Preservatives in glaucoma medication.The British journal of ophthalmology 2018; 102 (11):
1497-503.
2. Nakamura T, Yamada M, Teshima M, et al. Electrophysiological
characterization of tight junctional pathway of rabbit cornea treated
with ophthalmic ingredients. Biological & pharmaceutical
bulletin 2007; 30 (12): 2360-4.
3. Pellinen P, Lokkila J. Corneal penetration into rabbit aqueous humor
is comparable between preserved and preservative-free tafluprost.Ophthalmic Res 2009; 41 (2): 118-22.
4. Batra R, Tailor R, Mohamed S. Ocular surface disease exacerbated
glaucoma: optimizing the ocular surface improves intraocular pressure
control. Journal of glaucoma 2014; 23 (1): 56-60.
5. Baudouin C. Ocular Surface and External Filtration Surgery: Mutual
Relationships. Developments in ophthalmology 2017; 59 :
67-79.
6. Thygesen J. Glaucoma therapy: preservative-free for all? Clin
Ophthalmol 2018; 12 : 707-17.
7. Brignole-Baudouin F, Desbenoit N, Hamm G, et al. A new safety concern
for glaucoma treatment demonstrated by mass spectrometry imaging of
benzalkonium chloride distribution in the eye, an experimental study in
rabbits. PloS one 2012; 7 (11): e50180.
8. Stevens AM, Kestelyn PA, De Bacquer D, Kestelyn PG. Benzalkonium
chloride induces anterior chamber inflammation in previously untreated
patients with ocular hypertension as measured by flare meter: a
randomized clinical trial. Acta Ophthalmol 2012; 90 (3):
e221-4.
9. Rogov AG, Goleva TN, Sukhanova EI, et al. Mitochondrial Dysfunctions
May Be One of the Major Causative Factors Underlying Detrimental Effects
of Benzalkonium Chloride. Oxidative medicine and cellular
longevity 2020; 2020 : 8956504.
10. Kim M, Weigand MR, Oh S, et al. Widely Used Benzalkonium Chloride
Disinfectants Can Promote Antibiotic Resistance. Applied and
environmental microbiology 2018; 84 (17).